Washington Trust Bank bought a new position in shares of Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX – Get Rating ) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 34,219 shares of the pharmaceutical company's stock, valued at approximately $9,882,000. Vertex Pharmaceuticals comprises 1.1% of Washington Trust Bank's investment portfolio, making the stock its 29th biggest holding. Other institutional investors have also recently added to or reduced their stakes in the company.

https://www.dailypolitical.com/2023/04/25/washington-trust-bank-invests-9-88-million-in-vertex-pharmaceuticals-incorporated-nasdaqvrtx.html

#dailypolitical